Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration

Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration

Parkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurring in parkinsonian disorders, but NMS may occur in patients with progressive supranuclear palsy and multiple system atrophy. We report first patient with corticobasal degeneration (CBD) who developed...

Full description

Bibliographic Details
Main Authors:	Myung Jun Lee, Chul Hyoung Lyoo, Myung Sik Lee
Format:	Article
Language:	English
Published:	Korean Movement Disorder Society 2011-10-01
Series:	Journal of Movement Disorders
Subjects:	Corticobasal degeneration Neuroleptic malignant syndrome
Online Access:	http://e-jmd.org/upload/jmd-4-2-73-5.pdf

Similar Items

Corticobasal degeneration and corticobasal syndrome: A review
by: Vasilios C. Constantinides, et al.
Published: (2019-01-01)

Pharmacological interventions in corticobasal degeneration: a review
by: Leonardo Caixeta, et al.
Published: (2020-09-01)

Reversible splenial lesion syndrome in neuroleptic malignant syndrome.
by: Al-Edrus, Sharifah Aishah, et al.
Published: (2009)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01)

The Significance of Vascular Pathogenesis in the Examination of Corticobasal Syndrome
by: Anna Dunalska, et al.
Published: (2021-05-01)

Low dosage of aripiprazole induced neuroleptic malignant syndrome after interaction with other neuroleptic drugs
by: Albino Petrone, et al.
Published: (2013-09-01)

Cognitive dysfunction in corticobasal degeneration
by: Laís Machado de Oliveira, et al.

Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus
by: Ali Ertug Arslankoylu, et al.
Published: (2011-06-01)

Neuroleptic malignant syndrome: a fatal case with unusual features
by: U. M. Wariyapperuma, et al.
Published: (2014-12-01)

Neuroleptic Malignant Syndrome Associated with Lithium Toxicity
by: Vaibhav Patil, et al.
Published: (2016-07-01)

Neuroleptic malignant syndrome: a diagnostic dilemma in an unconscious patient—a case report
by: Swati Jain, et al.
Published: (2022-11-01)

Neuroleptic malignant syndrome for the emergency neurologist
by: Cristian Mihailescu
Published: (2010-09-01)

Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review
by: Federica Arienti, et al.
Published: (2021-01-01)

Neuroleptic malignant syndrome
by: Bino Rajamani, et al.
Published: (2016-01-01)

Neuroleptic Malignant Syndrome: A case report and a literature review
by: O. De Juan Viladegut, et al.
Published: (2022-06-01)

Neuroleptic Malignant Syndrome After the Use of Venlafaxine in a Patient with Generalized Anxiety Disorder
by: Tsung-Chien Lu, et al.
Published: (2006-01-01)

Pulmonary embolism in a patient with neuroleptic malignant syndrome
by: Mosaad Almegren
Published: (2018-12-01)

Neuroleptic malignant syndrome induced by concomitant use of risperidone and quetiapine
by: Mustafa Volkan Demir, et al.
Published: (2016-01-01)

The neuroleptic malignant syndrome – a practical challenge for every practitioner
by: Cristian Mihailescu
Published: (2011-06-01)

Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment
by: Manoj Kumar Sahoo, et al.
Published: (2014-01-01)

Neuroleptic Malignant Syndrome or Catatonia? A Case Report
by: Rodriguez Sebastian, et al.
Published: (2020-08-01)

Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
by: Ana Maia, et al.
Published: (2021-06-01)

Clozapine Induced Neuroleptic Malignant Syndrome
by: Yong Suk Jo, et al.
Published: (2017-08-01)

The Discourse Profile in Corticobasal Syndrome: A Comprehensive Clinical and Biomarker Approach
by: Isabel Junqueira de Almeida, et al.
Published: (2022-12-01)

A Case Report of Neuroleptic Malignant Syndrome during Methadone Therapy
by: MJ Nasr, et al.
Published: (2022-03-01)

Acute Colonic Pseudo-obstruction Induced by Neuroleptic Malignant Syndrome
by: Sung Ju Ryu, et al.
Published: (2021-06-01)

Levodopa-responsive depression associated with corticobasal degeneration: a case report
by: Tarakita N, et al.
Published: (2017-04-01)

Neuroleptic malignant syndrome – a case report
by: Marcin Makuch, et al.
Published: (2019-07-01)

A case of neuroleptic malignant syndrome following cardiac surgery
by: Atsushi Tamura, et al.
Published: (2017-06-01)

Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
by: Anish Shouan, et al.
Published: (2020-01-01)

Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate
by: Anish Shouan, et al.
Published: (2020-01-01)

Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
by: Manoj Kumar Sahoo, et al.
Published: (2017-01-01)

Olanzapine-Induced Neuroleptic Malignant Syndrome
by: Seyedhamze Hosseini, et al.
Published: (2017-05-01)

Fluvoxamine-induced neuroleptic malignant syndrome
by: Adarsh Bellad, et al.
Published: (2017-01-01)

Olanzapine-induced neuroleptic malignant syndrome
by: Pradeep Kumar Saha, et al.
Published: (2017-01-01)

An autopsy-proven case of Corticobasal degeneration heralded by Pontine infarction
by: Dallah Yoo, et al.
Published: (2021-04-01)

Acute Abdomen with Ileus: A Heralding Presentation of Neuroleptic Malignant Syndrome
by: Chukwunonso Chime, et al.
Published: (2018-09-01)

Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
by: Miguel Santos, et al.
Published: (2021-11-01)

Neuroleptic malignant syndrome after overdose of haloperidol – A case report
by: Nicole Kraaijvanger, et al.
Published: (2024-06-01)

Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report
by: Young Kyoung Sa, et al.
Published: (2013-03-01)